Nathaniel Weygant
机构: Professor, Fujian University of Traditional Chinese Medicine
每年引用次数
引用次数
引用: 2,005
H-指数: 28
I10-指数 : 34
出版物: 113
Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Yang Ge , Nathaniel Weygant , Dongfeng Qu , Randal May
International Journal of Cancer 143 ( 5) 1162 -1175
21
2018
Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple-negative breast cancer
Jie Li , Liya Liu , Youqin Chen , Meizhu Wu
Oncology Reports 47 ( 6) 1 -10
1
2022
Inhibition of DCLK1 with DCLK1-IN-1 suppresses renal cell carcinoma invasion and stemness and promotes cytotoxic T-cell-mediated anti-tumor immunity
Ling Ding , Yuning Yang , Yang Ge , Qin Lu
Cancers 13 ( 22) 5729
3
2021
Role of DCLK1 in oncogenic signaling
Qin Lu , Hailan Feng , Hong Chen , Nathaniel Weygant
International Journal of Oncology 61 ( 5) 1 -12
1
2022
Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids
Ling Ding , Yuning Yang , Qin Lu , Zhiyun Cao
Current Cancer Drug Targets 22 ( 3) 195 -208
1
2022
Identification of the putative intestinal stem cell marker DCAMKL-1 in Barrett’s esophagus and esophageal adenocarcinoma
Kenneth J Vega , Randal May , Sripathi M Sureban , Stan A Lightfoot
Journal of Gastroenterology and Hepatology 27 ( 4) 773 -773
8
2012
DCLK1 regulates ATR-DNA damage response for KRAS mutant lung cancer drug resistance and stemness
Courtney Houchen , Janani Panneerselvam , Priyanga Mohandoss , Nathaniel Weygant
Cancer Research 79 ( 13_Supplement) 2119 -2119
2019
Systemic delivery of CBT-15G DCLK1-targeted monoclonal antibody dramatically decreases tumorigenesis in a xenograft model of pancreatic cancer
Nathaniel Weygant , Dongfeng Qu , Randal May , Parthasarathy Chandrakesan
Cancer Research 76 ( 14_Supplement) 577 -577
5
2016
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof
Courtney Houchen , Sripathi M Sureban , Randal May , Dongfeng Qu
4
2017
Knocking down the expression of DCLK1 reduces mammary tumor formation, tumor cell self-renewal and metastasis: DCLK1 a novel therapeutic target in breast cancer
Parthasarathy Chandrakesan , Nathaniel Weygant , Dongfeng Qu , William Berry
Cancer Research 76 ( 14_Supplement) 2493 -2493
2
2016
DCLK1 a novel therapeutic target in non-small cell lung cancer
Parthasarathy Chandrakesan , Dongfeng Qu , Randal May , Nathaniel Weygant
Cancer Research 77 ( 13_Supplement) 4147 -4147
1
2017
Dietary Omega-3 Polyunsaturated Fatty Acids Increase Intestinal Crypt Stem Cell Survival Following Radiation Injury
Sripathi M Sureban , Altaf Mohammed , Randal May , Dongfeng Qu
Gastroenterology 150 ( 4 Supplement 1) S692 -S692
1
2016
Silencing DCLK1 prevents breast cancer cell self-renewal, epithelial mesenchymal transition, circulating tumor cells and metastasis
Parthasarathy Chandrakesan , Nathaniel Weygant , Vivian Taylor , William Berry
Cancer Research 75 ( 15_Supplement) 4220 -4220
1
2015
Dietary Pectin Increases Intestinal Crypt Stem Cell Survival Following Radiation Injury
Sripathi M Sureban , Randal May , Dongfeng Qu , Nathaniel Weygant
Gastroenterology 142 ( 5) S334 -S334
1
2012
Abstract LB219: DCLK1 is a novel therapeutic target for gastric and colorectal cancers as demonstrated by patient-derived organoids assays
Dongfeng Qu , Jinsen Shi , Zhiyun Cao , Eddie BAnnerman-Menson
Cancer Research 84 ( 7_Supplement) LB219 -LB219
2024
Anti-doublecortin-like kinase 1 antibodies and methods of use
Courtney W Houchen , Nathaniel Weygant , Dongfeng Qu , Randal May
2023
Microrna expression signatures for doublecortin-like kinase 1 (dclk1) activity
Courtney W Houchen , Nathaniel Weygant , Dongfeng Qu , Randal May
2019
DCLK1 is upregulated in melanoma and it is a novel predictive marker for survival and response
Dongfeng Qu , Nathaniel Weygant , Parthasarathy Chandrakesan , Kamille Pitts
Cancer Research 79 ( 13_Supplement) 4034 -4034
2019
A multigene recurrence signature identifies highly proliferative tumors that escape immune surveillance in early stage lung and pancreas adenocarcinoma
Nathaniel Weygant , Jiannan Yao , Dongfeng Qu , Parthasarathy Chandrakesan
Cancer Research 78 ( 13_Supplement) 2594 -2594
2018
Serum DCLK1 levels are elevated in melanoma patients and it is a novel predictive marker for survival and response
Dongfeng Qu , Nathaniel Weygant , Parthasarathy Chandrakesan , Kamille Pitts
Cancer Research 78 ( 13_Supplement) 3611 -3611
2018